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Introduction
The classical model of basal ganglia dysfunctions occurring in Parkinson's disease highlights the pathological imbalance between the 'direct' and 'indirect' pathways in patients with levodopa-induced dyskinesias (LIDs) (Obeso et al., 2000) . Although this model has been reinforced and modified to extend knowledge about the interplay between striatal nuclei and frontal cortex, its application has been shown to offer an inadequate description of clinical and experimental findings in patients with Parkinson's disease (Obeso et al., 2000; Morgante et al., 2006; Jenner, 2008) . For this reason, in recent years several alternative models have been proposed to better understand the pathophysiological mechanisms underlying motor fluctuations in Parkinson's disease (Carta et al., 2007; Cenci and Konradi, 2010; Ahmed et al., 2011) .
Our recent neuroimaging studies have shed new light on the pathophysiological mechanisms underlying LIDs (Cerasa et al., 2011 (Cerasa et al., , 2012 (Cerasa et al., , 2013a (Cerasa et al., , b, 2014 . Indeed, we demonstrated that patients with Parkinson's disease with LIDs are characterized either by dysfunctional coupling between the right inferior frontal cortex (IFC) and the supplementary motor area (SMA) during a simple motor task (Cerasa et al., 2012) or by an abnormal increase of grey matter volume in the IFC (Cerasa et al., 2011) . This latter finding has been confirmed using different population (Cerasa et al., 2013a) and neuroimaging metrics (Cerasa et al., 2013b) , and has already raised an interesting scientific debate on the toxic effects of levodopa on brain morphometry (Vernon and Modo, 2012; Cerasa et al., 2014) as well as on the hypothetical role of this area as a new target for brain stimulation useful to decrease the severity of LIDs (Cerasa and Quattrone, 2014a; Obeso and Strafella, 2014) .
The IFC is part of a well-known neural network involved in response inhibition (Aron and Poldrack, 2006) . Previous structural and functional MRI studies have demonstrated that this network is right-lateralized and comprised of the: IFC, SMA/preSMA, primary motor cortex (M1), subthalamic nucleus (STN), and striatum Li et al., 2008; Neubert et al., 2010) . The idea proposed by our group, discussed by Aron and Obeso (2012) , is that LIDs may rely on a reduced inhibitory control mediated by the IFC. What was clearly demonstrated by Aron et al. (2004) and confirmed by other authors (Forstmann et al., 2008; Hampshire et al., 2010; Neubert et al., 2010) was that the ability to control motor responses depends critically upon the right IFC, which is embedded in a three-way fronto-basal-ganglia network: the direct, indirect and hyperdirect pathways (Aron et al., 2014) . The direct pathway is mainly involved in facilitating the initiation and execution of voluntary movements, while the indirect pathway has been demonstrated to implement and regulate response inhibition (Nambu, 2004; Aron, 2007) . Furthermore, the hyperdirect pathway has been shown convey powerful direct excitatory effects from the frontal cortex (including preSMA and IFC) to the STN by passing the striatum (Nambu et al., 2002) providing a quick route for influencing the tonic inhibition of the basal ganglia output pathways for achieving inhibition of inappropriate or prepotent responses (Jahfari et al., 2011, Cerasa and Quattrone 2014b) .
Overall, what emerged from these studies was that striato-frontal dysfunctions characterizing Parkinson's disease, as well as the neural mechanisms regulating motor inhibition, might share similar neural pathways. Indeed, although idiopathic Parkinson's disease is primarily a disorder of response initiation characterized by an excessive motor inhibition (i.e. akinesia, bradykinesia), LIDs are clearly a clinical expression of disinhibition of movement. The presence of deficits in inhibitory control on tasks requiring inhibition of prepotent motor response has been widely reported in patients with Parkinson's disease (Obeso et al., 2011; Jahanshahi, 2013) and generally considered as a 'cognitive' consequence of the disease. Nonetheless, the idea that the neural networks subserving motor inhibition may influence the induction of LIDs is a new intriguing hypothesis.
In this multimodal work, we performed two independent resting state functional MRI and theta burst stimulation (TBS) experiments. In the first study, we aimed at revealing levodopa-induced changes in the resting state functional connectivity occurring in patients with Parkinson's disease with LIDs. As there are no functional MRI studies investigating pathological changes in the brain of patients with LIDs during the ON phase of levodopa treatment, we investigated the presence of different brain connectivity patterns comparing patients with Parkinson's disease with and without LIDs. In particular, we were interested in investigating the pattern of connectivity with the right IFC. Blood oxygen level-dependent functional MRI signal recorded while the subject lies at rest with eyes closed represents an important tool for understanding brain disorders in patients with Parkinson's disease (Wu et al., 2011; Esposito et al., 2013; Kahan et al., 2014) . Brain regions with similar functions have been shown to display functional connectivity during rest, which reflects the presence of direct and indirect anatomical pathways (Horn et al., 2014) . Next, in a second study using an independent group of patients with Parkinson's disease with LIDs, we tested the reliability of repetitive transcranial magnetic stimulation (TMS) over the right IFC to evaluate whether the expected altered connectivity centred on the right IFC may be considered as a consequence of LIDs or whether this has a critical role on the aberrant neural mechanisms contributing to the induction of involuntary movements, thus improving motor disabilities. Fundamentally, we hypothesized that: (i) levodopa replacement therapy influences the communication between the right IFC and brain regions involved in the primary motor pathways (motor/ premotor cortices, basal ganglia, STN and cerebellum) in patients with LIDs; and (ii) that IFC TBS has an antidyskinetic effect in patients with Parkinson's disease with LIDs, possibly through the modulation of cortico-cortical pathways originating from this area.
Subjects and methods

Subjects
Patients with diagnoses of idiopathic Parkinson's disease according to the United Kingdom Parkinson's Disease Society Brain Bank criteria (Hughes et al., 1992) were enrolled in this study. Inclusion criteria were: (i) a minimum 6-month duration of levodopa treatment; (ii) the presence or absence of peak-dose LIDs following an acute levodopa test observed by the examining neurologist on the occasion of the last visit; LIDs were defined as 425% of waking hours (item 32 of UPDRS 5 2) and bothersome (item 33 5 2); (iii) stable medication dose for 4 weeks; (iv) no evidence of vascular brain lesions, brain tumour or brain atrophy; (v) no evidence of dementia or depression symptoms according to DSM-IV criteria; (vi) no use of antidepressant, anxiolytic or antipsychotic drugs that could affect cerebral blood flow; (vii) righthandedness; (viii) absence of chronic medical conditions (heart disease, hypertension, or diabetes), and of contraindications for MRI and TBS; (ix) no excessive movement artefacts during functional MRI experiment; and (x) ability to tolerate the withdrawal of dopaminergic medication before functional MRI session.
According to these criteria, we enrolled two independent groups, one for the functional MRI and one for the TBS experiment. The characteristics of the patients enrolled for the neuroimaging (primary group) and TBS (secondary group) studies are shown in Table 1 .
For the functional MRI study 66 case patients with clinical diagnoses of Parkinson's disease were consecutively selected among the outpatients of the Institute of Neurology of the "Magna Graecia" University of Catanzaro, Italy. Among this group of treated patients with Parkinson's disease, 34 were dyskinetic and 32 were non-dyskinetic. Dyskinetic and nondyskinetic patients were then individually matched by a computer-generated program according to their disease duration ( AE 16 months). A total sample of 12 pairs was then available for the analysis. All dyskinetic patients exhibited mild peakdose choreic dyskinesia. Dyskinesias were predominately distributed in the upper body or lower extremities with hyperkinetic movements mostly affecting the right side of the body (84%). All patients with Parkinson's disease were treated with levodopa with additional dopamine agonists ( Supplementary Table 1 ). Before the OFF and ON phase functional MRI sessions, patients underwent clinical assessments, including Hoehn and Yahr staging, Unified Parkinson's Disease Rating Scale (UPDRS) and Abnormal Involuntary Movement Scale (AIMS).
For the TBS experiments, 11 patients with Parkinson's disease suffering from disabling peak-dose dyskinesias after levodopa ingestion were enrolled at Santa Lucia Foundation in Rome. Eight patients were enrolled for the main experiment in which TBS protocols were delivered over the right IFC and eight (five of whom participated in the main experiment) were recruited for a control experiment in which TBS protocols were applied over the left M1 (Table 1) .
Informed consents and Ethics Committee approvals were obtained for all patients enrolled in the two experiments, according to the Declaration of Helsinki.
Neuropsychological assessment
All patients enrolled for the functional MRI experiment completed an extensive series of neuropsychological tests (Passamonti et al., 2013) , which were administered by an experienced clinical neuropsychologist blind to any other result. Neuropsychological evaluations were performed at the same time as the MRI and neurological exams, evaluating the following neuropsychological measures: (i) executive control (Frontal Assessment Battery, Modified Card Sorting Test and Stroop task); (ii) attention and working memory (Digit Span Forward and Backward); (iii) short-and long-term verbal memory (Rey Auditory Verbal Learning Test); (iv) verbal fluency and language comprehension (Word List Generation, Token Test); and (v) visual-spatial skills (Judgement of Line Orientation) and general cognitive status (Mini-Mental State Examination). We further investigated the presence of impulsivity trait and depressive and anxiety symptoms using the Barratt's Impulsivity Scale, Beck Depression Inventory and Hamilton Rating Scale Anxiety, respectively. Neuropsychological data are shown in Supplementary Table 2 .
Resting state functional MRI experiment
The resting-state functional MRI run lasted 57 min. Particular care was taken to restrain the subjects' movements with cushions and adhesive medical tape. All patients were scanned twice in the same morning immediately before (practical 'OFF phase': 12 h after last medication) and $60 min after ('ON phase') drug administration, consistent with the expected time peaks of LIDs. In accordance with a previous imaging study (Pavese et al., 2006) , we calculated the approximate timing of LIDs onset based on patient's personal medication history. This prescan evaluation was performed for 1 week before conducting the functional MRI experiment. After overnight withdrawal of anti-parkinsonian medications, patients were examined the morning before and after taking their established dopaminergic therapy. This procedure helped us to define the average individual times taken by each dyskinetic patient to switch from an OFF to an ON state. This information was subsequently used on the day of the experiment to start functional MRI acquisition at the time immediately before the expected commencement of LIDs. To better evaluate this condition (and to avoid motion artefacts), patients were also continuously monitored by clinicians (G.D. and G.M.) inside the scanner room. When the expected timing of patients' responses to levodopa treatment was reached, the functional MRI session was started (Supplementary Video 1). A physician remained inside the scanner room to visually observe the emergence of involuntary movements. If dopaminergic levels reached the threshold for triggering peak-of-dose dyskinesias, MRI measurements were immediately stopped. None of the patients with Parkinson's disease with LIDs reached the peak-of-dose dyskinesias during functional MRI session.
The levodopa treatment was executed either at the first or second functional MRI session in a counterbalanced order across patients. In the OFF phase, individuals were asked not only to interrupt levodopa medication, but also dopamine agonists and/or amantadine drugs.
Resting state functional MRI acquisition and preprocessing
Scanning was performed on a 3 T scanner (Discovery MR750 General Electric) with an 8-channel head coil. A gradient-echo echo planar (EPI) T 2 *-weighted pulse sequence (repetition time/ echo time: 2000/25 ms; number of axial slices = 39; field of view = 24 mm; thickness/gap = 3/0.8 mm; matrix size = 96 Â 96) was used. During the functional scan, subjects were asked to simply stay motionless, awake and relaxed with their eyes closed; no visual or auditory stimuli were presented at any time during functional scanning.
Data of each functional MRI scan contained 200 time points. All functional images were preprocessed using a tool that is part of the FMRIB's Software Library (http://www. fmrib.ox.ac.uk/fsl MELODIC). Images were slice-time corrected and aligned to the Montreal Neurological Institute's (MNI) 152 standards space using linear registration with 12 degrees of freedom. Afterwards, the images were spatially smoothed using a Gaussian kernel of 8 mm full-width at half-maximum. In addition, high-pass temporal filtering was applied to remove very low-frequency drifts and physiological high-frequency noise (Biswal et al., 1995) . Finally, imaging data were then temporally concatenated across subjects to create a single 4D data set for each subject.
Each subject's head motion parameters were examined. No subject's data set had 42 mm maximum translation in x, y, or z, or 1 mm of maximum rotation about three axes. As correlation analysis is sensitive to gross head motion, we characterized the head motion as an index representing the peak displacement that was determined by using a previously validated method applied on patients with Parkinson's disease (Wu et al., 2011) . Specifically, we calculated the Euclidian distance travelled by each subject's head from the first to the last scan (i.e. combining the movements in the three axes into one value), separately for translation (x, y and z direction) and for rotation (pitch, roll and yaw). Then, a two-way ANOVA test was performed on the peak displacement to examine betweengroup differences in head motion. The interaction effects of group (patients with LIDs versus patients without LIDs) and levodopa phase (OFF versus ON) did not reveal significant differences either for the six motion parameters (translation and rotation) or for the calculation of Euclidian distance ( Supplementary Fig. 1 ). However, we detected some significant differences investigating the main effects of levodopa phase. Specifically, all patients with Parkinson's disease in the ON phase moved more than patients in the OFF phase, both for the translation (z direction; P = 0.003) and for rotation (pitch parameter; P = 0.002).
Functional connectivity analysis
We defined the right IFC as region of interest. The MNI coordinates for this seed were derived from our past functional MRI study (x: 42; y: 32; z: 12) where we detected altered activity in LID patients during motor task (Cerasa et al., 2012) . Next, a 5-mm sphere around this coordinate was created and used to extract data for functional connectivity analysis in the resting state. A seed reference time course was obtained by averaging the time courses. Correlation analysis was carried out between the seed reference and the whole brain in a voxel-wise manner. In the correlation analysis, the six head motion parameters were included as nuisance covariates. We did not apply global signal regression to avoid the introduction of artificial negative correlations that may result from removal of the global signal (Murphy et al., 2009; Wu et al., 2011) . The individual correlation coefficient (r) maps were converted into z-maps by Fisher's Z-transform to improve the normality of the data (Press et al., 1992; Lowe et al., 1998) . The individual z-value was entered into a random effect one-sample t-test in a voxel-wise manner to determine brain regions showing significant connectivity with each 'seed' in the resting state within each group. Then, to assess the main/interaction effects of group (Parkinson's disease with LIDs versus patients without LIDs) and levodopa phase (OFF versus ON) in connectivity with the IFC, a second-level ANOVA model was used.
In the current study, positive connectivity means that the spontaneous signal fluctuations in brain networks are inphase with the fluctuations observed in the corresponding seed region; whereas negative connectivity means that the spontaneous signal fluctuations are antiphase related with the fluctuations observed in the corresponding seed region (Fox et al., 2005) . A family-wise error (FWE) corrected threshold of P 5 0.05 within regions of interest was used for either within or between group results. Based on previous findings, we decided to use the left IFC, bilateral SMA/preSMA, M1, STN, thalamus, striatum and cerebellum as regions of interest given their critical engagement in LIDs-related pathological mechanisms (Rascol et al., 1998; Brooks et al., 2000; Obeso et al., 2000; Cerasa et al., 2014) and motor inhibition processing (Aron et al., 2014) . In addition, to explore whether the interactions of brain networks correlate with the disease severity, a correlation analysis of functional connectivity results against the AIMS scores was performed in patients with Parkinson's disease with LIDs.
Theta burst stimulation experiments
In this experiment patients had fasted and were in withdrawal of therapy since the previous night (CAPIT). After 12 h of overnight medication withdrawal, patients received 125% of their usual morning levodopa equivalent dose as immediate release levodopa/carbidopa (Koch et al., 2009) . The assessment in each video-recorded session consisted of a complete UPDRS III and AIMS assessment. The degree of LIDs was assessed individually in neck, trunk, right upper limb, right lower limb, left upper limb and left lower limb and scored as follows: 0, none; 1, slight; 2, mild; 3, moderate; and 4, severe. Overall severity was expressed by the sum of scores in all regions (0-24). Following levodopa administration, UPDRS III and AIMS were calculated every 15 min for 1 h (t0, t15, t30, t45, t60). A complete evaluation lasted $3-4 min at t0. In three separate sessions performed 1 week apart continuous TBS, intermittent TBS or sham continuous TBS were applied over the right IFC, immediately after levodopa administration. The order of the sessions was pseudo-randomized across patients. Two blinded raters (L.B. and M.S.B.), experts in the field of movement disorders, rated videotapes independently to provide AIMS and UPDRS scores. Both video-raters were blinded to repetitive TMS, and the scores were generated after a consensus was reached comparing the individual scores. To account for the variability of levodopa effect, particularly on LIDs, the three sessions were performed in consecutive weeks at the same hour of the day, and in the same pharmacological conditions.
A MagStim Super Rapid magnetic stimulator (Magstim Company) connected with a figure of 8 coil with a diameter of 70 mm was used to deliver repetitive TMS over the scalp site corresponding to the right IFC. The magnetic stimulus had a biphasic waveform with a pulse width of $300 ms. During the first phase of the stimulus, the current in the centre of the coil flowed toward the handle. For continuous TBS, three pulse bursts at 50 Hz were repeated every 200 ms for 40 s (Huang et al., 2005) over the right IFC (600 pulses). For intermittent TBS, three pulses bursts at 50 Hz were repeated at a rate of 5 Hz; there were 20 trains of 10 bursts given at 8-s intervals (600 pulses in total). Sham stimulation was delivered through a 7 cm figure of 8 focal coil angled at 90 with only the edge of the coil resting on the scalp. In every protocol, repetitive TMS were delivered at 80% of the active motor threshold (Huang et al., 2005) . Active motor threshold for the first dorsal interosseus was tested over the right motor cortex. The coil position for the right IFC was defined and monitored throughout the experiment with the SofTaxic Navigator system (Electro Medical Systems). The position was precisely determined using individual structural MRI to localize the sites and adjusted with respect to individual sulcal landmarks in each participant. To target the IFC the coil was positioned over the caudal portion of the pars opercularis of the inferior frontal cortex, with the handle pointing forward. The mean Talairach coordinates used in the present study to target the IFC were x = 50.9 AE 3.1; y = 29.6 AE 14.5; z = 19.4 AE 3.3.
The IFC TMS paradigm was completed by an additional control experiment useful to test for the specificity of the above described results by applying the same protocol over the left M1 in a sample of eight patients with Parkinson's disease with LIDs. For the left M1 TBS the coil was positioned over the hotspot of the right first dorsal interosseous (Huang et al., 2005) .
Statistical analysis
Statistical analyses of functional MRI data were performed with STATISTICA Version 6.0 (www.statsoft.com). Assumptions for normality were tested for all continuous variables by using the Kolmogorov-Smirnov test. In the first experiment, all variables were normally distributed, except for Hoehn and Yahr, and Modified Card Sorting Test scores. Otherwise, in the second experiment clinical scores were not normally distributed. The ANOVA, unpaired t-test, Mann-Whitney U-test and 2 were used appropriately. All statistical analyses had two-tailed alpha levels of 50.05 for defining significance. For the repetitive TMS experiment, non-parametric Wilcoxon tests were applied on mean AIMS and UPDRS scores for each session. For all statistical analyses, a P-value of 50.05 was considered to be significant.
Results
Functional connectivity of the right IFC in each group
Before levodopa intake during the resting state, functional MRI analysis showed that the right IFC of patients with Parkinson's disease with LIDs showed significant positive connectivity with the left IFC, preSMA, bilateral putamen, bilateral thalamus and bilateral STN and had significant negative connectivity with the bilateral anterior cerebellum (one sample t-test, P 50.05, FWE corrected; Table 2 ). Interestingly, in the ON phase the overall pattern of connectivity remained the same, except for the left M1. Indeed, levodopa replacement modulated specifically the connectivity between the right IFC and the left M1, which resulted to be negatively correlated.
In the OFF phase, the right IFC of patients with Parkinson's disease without LIDs showed a different pattern of connectivity from that detected in LIDs patients. Indeed, significant positive connectivity was only detected with the left IFC, SMA, right putamen and bilateral STN, together with significant negative connectivity with the bilateral anterior cerebellum. Interestingly, levodopa replacement produced an overall enhancement of functional connectivity. Indeed, apart from the regions described above, in the ON phase patients without LIDs showed additional significant positive connectivity with the preSMA, bilateral M1, and left putamen, while the connectivity with the right cerebellum disappeared.
Functional connectivity of the right IFC: the main/interactive effects of group and levodopa phase
Investigating the main effect Group (independent of levodopa phase) as well the main effect of Levodopa phase (independent of group), no significant functional change was detected. In other words, the connectivity of the right IFC was similar between Parkinson's disease with or without LIDs or between OFF and ON phases. When we investigated the interaction effects, two significant clusters emerged. In patients with LIDs during the ON phase, the right IFC showed significant negative connectivity with the left M1 (MNI local maxima: x = À6, y = À28, z = 78; F = 19.24; P FWE-ROI = 0.01) and positive connectivity with the right putamen (MNI local maxima: x = 28, y = 4, z = 8; F = 16.44; P FWE-ROI = 0.02). This pattern of connectivity was totally inverted in patients with Parkinson's disease without LIDs (Fig. 1 ).
Correlation analysis
Correlation analysis between connectivity t-score and the AIMS scores in brain areas that showed significant connection with the right IFC revealed significant relationships with the same brain regions detected in the ANOVA analysis. In fact, in patients with LIDs during the ON phase we detected a negative correlation in the left M1 (MNI local maxima: x = À 12, y = À24, z = 80; T-value = 4.15; P FWE-ROI = 0.03) and a positive correlation in the bilateral putamen (MNI local maxima: x = 12, y = À10, z = À8; Tvalue = 4.82; P FWE-ROI = 0.002; MNI local maxima: x = À10, y = À12, z = À6; T-value = 4.21; P FWE-ROI = 0.005 for the right and left hemispheres, respectively). Moreover, extending this analysis to other regions of interest, we found an additional significant association between increasing motor disability and increasing brain connectivity of the IFC with the bilateral STN (MNI local maxima: x = 16, y = 10, z = À 2; T-value = 6.82; P FWE-ROI = 0.01; MNI local maxima: x = À 10, y = 8, z = À4; Tvalue = 5.83; P FWE-ROI = 0.03 for the right and left hemispheres, respectively) (Fig. 2) .
Theta burst stimulation data
The procedure (Fig. 3) was well tolerated by all subjects. The mean patients' active motor threshold taken with the MagStim Super Rapid magnetic stimulator was 46.2 AE 8.5% of maximum stimulator output. Mean UPDRS and AIMS score did not differ at baseline in the three (continuous TBS, intermittent TBS, sham) conditions, moreover the analysis of AIMS and UPDRS scores for each body segment separately showed highly reproducible distribution in each subject in the three sessions.
Wilcoxon Test revealed that motor abilities scored by the mean UPDRS section III were not modified by any TBS condition (Fig. 4A) , whereas following continuous TBS, but not intermittent TBS, global AIMS scores were decreased in comparison with sham continuous TBS. This was evident at t30 (4.50 AE 1.30 versus 6.33 AE 1.42; P = 0.04) (Fig. 4B) following levodopa administration. When analysing LIDs separately for left and right body side we did not find significant differences (all P's 4 0.05) ( Fig. 4C and D) . Finally, when TBS trains were applied over the left M1 we did not find any effect on AIMS and UPDRS scores ( Fig. 4E and F) . in the pathophysiological mechanisms of LIDs. To this end, we performed two different experiments employing two independent groups of Parkinson's disease with the aim: (i) to explore the dopaminergic-induced modulation of the resting state neural connectivity in patients with Parkinson's disease with and without LIDs following levodopa administration; and (ii) to determine the influence of TBS protocol applied over the IFC in reducing hyperkinetic motor disorders. Our functional MRI study revealed that patients with LIDs are characterized by altered patterns of functional connectivity between the right IFC and the controlateral M1 and the ipsilateral putamen, which emerged when switching from the OFF to the ON phase of levodopa treatment. Although this first set of findings provides a significant advance in understanding the neural basis of LIDs, a fundamental conundrum persists: do these abnormal functional changes have a critical role in the neural network contributing to the manifestation of these involuntary movements or should these only be considered as a consequence of having long-term hyperkinetic movements (Aron and Obeso, 2012 )? To answer this critical question we performed an additional neurophysiological experiment evaluating the effect of brain stimulation over this prefrontal region in a group of dyskinetic patients who took a supramaximal dose of levodopa. Hypothetically, the lack of significant effects in ameliorating motor symptoms should confirm the latter hypothesis. Instead, in accordance with our a priori hypothesis, patients with LIDs showed a reduction of motor disability (AIMS scores) induced by TBS stimulation. Thus, our multimodal neurophysiological study clearly demonstrated that a network centred on the right IFC is critically involved in LIDs.
The new pathophysiological hypothesis of LIDs: functional MRI evidence
The first piece of functional MRI data relates to the presence of reduced communication between the IFC and the M1 in patients with Parkinson's disease with LIDs after levodopa medication (Fig. 1) . Although, the significance of negative correlations between brain regions in functional connectivity analysis remain unclear, it has been suggested that they arise between functional systems with apparently opposite goals or may reflect antagonistic influences of one network on another (Fox et al., 2005; Kelly et al., 2008) . With this in mind, we speculate that this pattern of altered connectivity characterizing patients with Parkinson's disease with LIDs in the ON phase may reflect a pathological inhibitory control of the IFC over the primary motor output pathway. Consistent with this view, a series of neurophysiological studies have investigated the meaning of the inhibitory influence of the right IFC over the M1 Figure 1 Seed-based analysis of the functional connectivity with the right IFC (blue circle on the left) in the resting state. We depict a significant (FWE 5 0.05) Group Â Levodopa phase interaction effect in the connectivity between the right IFC with the left primary motor cortex and right putamen. In particular, we find a reduced communication between the right IFC and the left motor cortex in the patients with Parkinson's disease with LIDs during the ON phase that is coupled with an increase in connectivity with the right putamen. Otherwise, levodopa treatment in patients with Parkinson's disease without LIDs would seem to restore and normalize the functional connectivity of the IFC. The colour bar represents F-statistics. Dysk = patients with Parkinson's disease with levodopa-induced dyskinesias; NoDysk = patients with Parkinson's disease without levodopa-induced dyskinesias; BOLD = blood oxygen level-dependent; IFC = functional connectivity.
during action control in healthy subjects Verbruggen and Logan, 2008; Buch et al., 2010; Neubert et al., 2010; Vossel et al., 2011) . Overall, inhibitory effects have mainly been reported during stopping of motor responses (i.e. Go/NoGo tasks), whereas during a normal action selection, a facilitatory effect of the right IFC on the left M1 was reported (van Campen et al., 2013) . Although we have investigated patients in a condition of rest, the fact that levodopa administration increased the connectivity between the IFC and the M1 in patients without LIDs characterized by excessive motor inhibition (i.e. bradykinesia), suggests the presence of facilitatory effects or normalization of cortical functional connectivity. In contrast, the decreased communication between the IFC and M1 in patients where drug treatment induces disinhibition of movements might indicate a tentative role of the IFC to inhibit the M1 activity and output. Another aspect of this finding is worth noting, namely the altered interhemispheric (right versus left) communication between the IFC and the M1. Several TMS and functional MRI studies demonstrated that response inhibition is implemented via functional and synchronized activities in the IFC-SMA/preSMA-striatum-M1 pathway (Swann et al., 2009; Neubert et al., 2010; Zandbelt et al., 2013) . In fact, converging lines of evidence confirmed that the right IFC exerts motor control over the M1 either via corticobasal ganglia pathways including the striatum (Aron and Poldrack, 2006) , or via cortico-cortical pathways through the SMA/preSMA (Zandbelt et al., 2013) . Moreover, a recent work combining TMS with DTI provided direct evidence that there are multiple routes involved in right IFC/left M1 interactions during action inhibition: a subcortical route (right IFC!globus pallidus!STN!M1) being used at longer latencies and a direct cortical route (IFC!M1) at shorter latencies (Neubert et al., 2010) . However, what clearly emerged from these studies was that the inhibitory control exerted by the right IFC over the M1 is bilateral. It is possible that our current functional MRI data showed an altered interhemispheric (right versus left) communication between the IFC and the M1 because of predominant hyperkinetic movements on the right side of the body among patients with LIDs. Another intriguing piece of evidence was the increased connectivity between the right IFC and the right putamen in patients with LIDs relative to patients without LIDs. Several TMS and DTI studies demonstrated tight connections between these regions. King et al. (2012) found that some specific fibre tracts are correlated to motor performance during a response inhibition task: tracts connecting the pre-SMA/SMA with the striatum and other tract linking the IFC with the striatum/STN. Moreover, Zandbelt et al. (2013) demonstrated that repetitive TMS over the right IFC and SMA was associated with shorter stop-signal reaction time and increased M1 deactivation together with increased right putaminal activation during a stop inhibition functional MRI task. For this reason, consistently with our previous hypothesis, we speculate that the increased communication between the right IFC and the putamen in patients with LIDs might reflect a (failed) tentative of the motor inhibition network to modulate another fronto-striatal network (direct pathway?) involved in neurodegenerative processes of LIDs.
The new pathophysiological hypothesis of LIDs: transcranial magnetic stimulation evidence
We tested different inhibitory and facilitatory forms of IFC TBS in comparison with sham stimulation. We found a selective decrease in the development of LIDs after a supramaximal dose of levodopa that was evident after right IFC continuous TBS, but not after intermittent TBS. The continuous TBS protocol is known to induce long-term depression-like after effects when applied over the primary motor cortex (Huang et al., 2005) . Therefore we can hypothesize procedure. In each session repetitive TMS was applied in different conditions immediately after L-DOPA ingestion. The assessment in each session consisted of a complete UPDRS and AIMS calculated every 15 min for 1 h (t0, t15, t30, t45, and t60) after L-DOPA ingestion. For continuous TBS, three pulse bursts at 50 Hz were repeated every 200 ms for 40 s (Huang et al., 2005) over the right IFC (600 pulses). For intermittent TBS, three pulses bursts at 50-Hz were repeated at a rate of 5 Hz; there were 20 trains of 10 bursts given at 8-s intervals (600 pulses in total). Sham stimulation was delivered through a 7 cm figure of 8 focal coil angled at 90 with only the edge of the coil resting on the scalp. cTBS = continuous TBS; iTBS = intermittent TBS. that the reduction of LIDs observed in our sample of patients with Parkinson's disease could involve similar neurophysiological mechanisms within the IFC-related cortical circuits. With this perspective, the reduction of LIDs after inhibitory trains of continuous TBS is in line with previous evidence suggesting that during motor fluctuations there is an overexcitability of the cortical motor network (Rascol et al., 1998; Brooks et al., 2000) . This overactivity of the motor cortical regions has been demonstrated to be (partially) counteracted by the application of inhibitory repetitive TMS trains over the SMA (Koch et al., 2005 (Koch et al., , 2009 Brusa et al., 2006) . The fact that we demonstrated a similar effect also modulating the activity of the IFC further confirmed the evidence that the IFC and SMA regions act together for modulating the activity of motor circuits (Aron et al., 2014) . However, we also provided evidence on the lack of anti-dyskinetic effects when inhibitory repetitive TMS trains were applied over the M1 in patients with LID. This is not surprising as a previous pilot study (Wagle-Shukla et al., 2007) did not demonstrate a clear benefit in improving dyskinesias when repetitive TMS was applied over the M1. For this reason, considering the abovementioned SMA TMS experiments (Koch et al., 2005; Brusa et al., 2006) together with previous neuroimaging functional/structural studies (Cerasa et al., 2011 (Cerasa et al., , 2012 (Cerasa et al., , 2013a describing neural abnormalities in the IFC and SMA (but not in the M1), we may conclude that these prefrontal regions are critical hubs in the brain networks underlying LIDs mechanisms.
On the basis of the current findings we may extend the classical vision of LIDs pathophysiology proposing that these motor symptoms are influenced by altered functionality of the neural network deputed to control of motor inhibition. Within this model, the above described overactivity of the frontal cortical motor network in LIDs could lead to a disruption of the coherent signalling related to the control of involuntary movement. IFC continuous TBS could reduce LIDs directly by decreasing the increased state of IFC activity through long-term depression-like mechanisms or indirectly by rebalancing the altered pattern of connectivity observed in the resting state functional MRI experiment. However, it is important to note that TBS of the IFC not only induces a local modulation of the neural activity, but also affects the most prominent cortical connections of the stimulated areas, causing widespread changes in network connectivity (Gratton et al., 2013) . Hence it is likely that IFC TBS could have induced a cascade of neurophysiological changes in the connectivity with all brain regions involved in primary motor circuit and functionally related to the activity of the right IFC, such as: preSMA/SMA, M1, striatum and cerebellum.
Future applications of functional neuroimaging in patients with Parkinson's disease with LIDs
It is important to note that MRI-based methods have intrinsic limitations when applied on patients with LIDs, namely the contamination of functional data due to motion artefacts. Although we have addressed this issue using several strategies, we acknowledge that our procedure to investigate the ON state of patients with LIDs immediately before the expected time peaks of plasma levodopa levels (necessary to avoid motion artefacts) might introduce between-subject variability in clinical characteristics. For this reason, we have started a new protocol for improving the investigation of functional changes following levodopa ingestion in patients with LIDs using functional near infrared spectroscopy. This technique has a higher ecological validity and is unique in visualizing cortical brain activation during gross movements, and may be useful to detect in vivo neural changes underlying the emergence of LIDs. We retain that with this neuroimaging method we could provide unquestionable evidence on the role of the IFC in pathophysiological mechanisms of LIDs.
Future applications of TMS protocol in patients with Parkinson's disease with LIDs
It is possible that the above described alterations of the neural network deputed to the control of movement inhibition could imply a decrease of the inhibitory topdown control of the right IFC on the controlateral M1. This hypothesis could be tested by adopting multifocal TMS protocols in the context of movement inhibition tasks ) aimed at assessing eventual task-related changes in the inhibitory influences of the IFC on M1 in patients with LIDs. Moreover, combined TMS/EEG protocols (Veniero et al., 2013) could measure eventual changes in the coherence of oscillatory activity related to movement inhibition. The effects of IFC continuous TBS could be associated with changes in local betaband coupling, which may constitute a risk factor for the development of motor response fluctuations or dyskinesias (Stoffers et al., 2008) . Finally, the clinical impact of prolonged sessions of continuous TBS when applied over the right IFC in patients with Parkinson's disease with LIDs remains to be established. We recently reported that continuous TBS of the lateral cerebellum induced a reduction of LIDs that lasted up to 1 month after the end of a 2-week period of daily stimulation (Koch et al., 2009) . It is possible that longer sessions of continuous TBS of the IFC could induce similar long-lasting beneficial effects; hence, further studies could be important to show if the clinical improvement is associated with changes in the structural and functional network centred on the right IFC.
Conclusion
In sum, we provide novel evidence that patients with Parkinson's disease with LIDs are characterized by functional abnormalities of a cortical-subcortical network centred on the right IFC and that non-invasive stimulation of this area counteracts the development of LIDs after levodopa administration. Although neuroimaging and electrophysiological measures have been conducted on different groups of patients, our multimodal findings enlarge current knowledge on the pathophysiological mechanisms underlying LIDs, moving from classical striato-motor circuitry towards a broader cortico-cortical network. We retain that this study will open new scenarios on the development of therapeutic protocols for inducing persistent beneficial clinical effects in patients with Parkinson's disease with LIDs.
